Hepatitis C Virus NS3/4A Protease Inhibitor drugs

3 medications in the FDA established pharmacologic class “Hepatitis C Virus NS3/4A Protease Inhibitor”.

DrugTypeNDC products
Mavyret
Glecaprevir and Pibrentasvir		Rx2
Vosevi
SOFOSBUVIR, VELPATASVIR, and VOXILAPREVIR		Rx1
Zepatier
elbasvir and grazoprevir		Rx1